ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: Annals of Thoracic Surgery
Author(s): Talha Shaikh, Karen Ruth, Walter J. Scott, Barbara A. Burtness, Steven J. Cohen, Andre A. Konski, Harry S. Cooper, Igor Astsaturov, Joshua E. Meyer

The authors retrospectively analyzed pathologic response rates and their relation to the interval between completion of induction therapy and esophagectomy for esophageal cancer in 88 patients.  Complete response rates increased from 12.5% to 40.9% among quartiles as the interval increased from <45 days to >63 days.  There was no increase in morbidity associated with longer intervals to surgery.

Source: Annals of Thoracic Surgery
Author(s): Maria Restrepo, Elaine Tang, Christopher M. Haggerty, Reza H. Khiabani, Lucia Mirabella, James Bethel, Anne Marie Valente, Kevin K. Whitehead, Doff B. McElhinney, Mark A. Fogel, Ajit P. Yoganathan

Patients who underwent a Fontan procedure for single ventricle physiology were evaluated with serial cardiac MR over time to identify changes in vessel characteristics and their relationship to flow.  Although vessel diameter increased over time, normalized diameters decreased.  This was not associated with changes in flow, but hemodynamic efficiency declined over time. 

Source: Annals of Thoracic Surgery
Author(s): Vinod H. Thourani, Rakesh M. Suri, Rebecca L. Gunter, Shubin Sheng, Sean M. O’Brien, Gorav Ailawadi, Wilson Y. Szeto, Todd M. Dewey, Robert A. Guyton, Joseph E. Bavaria, Vasilis Babaliaros, James S. Gammie, Lars Svensson, Mathew Williams, Vinay Badhwar, Michael J. Mack

Outcomes of surgical AVR were summarized from the STS Cardiac Surgery Database 2002-2010 to establish contemporary data for different surgical risk groups (low <4% risk, intermediate 4%-8% risk, high >8% risk).  80% were low risk, 6% were high risk.  Hospital mortality was lower than predicted by STS PROM for all groups (low: 1.4$ vs 1.7%; intermediate 5.1% vs 5.5%; high 11.8% vs 13.7%). 

Source: Annals of Thoracic Surgery
Author(s): Michael A. Borger, Vadim Moustafine, Lenard Conradi, Christoph Knosalla, Markus Richter, Denis R. Merk, Torsten Doenst, Robert Hammerschmidt, Hendrik Treede, Pascal Dohmen, Justus T. Strauch

This study randomized 100 patients with AS to full sternotomy AVR with a conventional prothesis or hemisternotomy with a rapid deployment prosthesis.  CPB times were similar, but Ao crossclamp times were 24% shorter in the rapid deployment group.  Acute outcomes were similar.  The rapid deployment group had a lower transvalvular gradient and a lower prevalence of prosthesis mismatch at 3 months. 

Source: Royal College of surgeons of England Bulletin
Author(s): C Limb, D Limb, R Limb - Consultant orthopaedic surgeons

Read this amusing article that documents a series of names of genuine doctors on the  UK  GMC registar such as psychiatrists called Dr Bhatti, Dr Moodie, a Genitourinary doctor called Dr Hussey and general surgeons called Mr Gore and Mr butcher ! 

Got any of your own ? Post them now in the comments section 

 

 

Source: Journal of the American College of Cardiology
Author(s): Zugui Zhang; Paul Kolm; Maria V. Grau-Sepulveda; Angelo Ponirakis; Sean M. O’Brien; Lloyd W. Klein; Richard E. Shaw; Charles McKay; David M. Shahian; Frederick L. Grover; John E. Mayer; Kirk N. Garratt; Mark Hlatky; Fred H. Edwards; William S. Weintraub

In 2012 the American College of Cardiology Foundation and the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies (ASCERT) compared the 5 year effectiveness of CABG versus PCI. The registry data is now linked with Centeres for Meidcare and Medicaid Services Claims data in order to study the long-term cost-effectiveness of the two strategies. The authors found that the life-time incremental cost-effectiveness ratio of CABG versus PCI was approximately $30,000/QALY gained, a value that is generally considered economically attractive.

Source: YOUTUBE
Author(s): Professor Tristan Yan

This patient presented with a large distal arch and proximal descending aortic aneurysm (7 cm). He underwent a Total Arch Replacement and Frozen Elephant Trunk Procedure using the Thoraflex Hybrid Graft (Vascutek Terumo). The entire operation was performed via a hemi-sternotomy (half incision size). He had an enhanced recovery and was discharged home on postoperative day 6.

Source: World Journal for Pediatric and Congenital Heart Surgery.
Author(s): Bahaaldin Alsoufi, Michael Wolf, Phil Botha, Brian Kogon, Courtney McCracken, Alexandra Ehrlich, Kirk Kanter, and Shriprasad Deshpande

 

 

Overall, 13.4% of single ventricle patients received ECMO support following the Norwood operation. Although there were no preoperative or operative predictors of the requirement of ECMO support following the Norwood operation, unplanned reoperation for shunt problems or technical complications was associated with an increased need for ECMO use. Although hospital death was high at 58% in patients who required
postoperative ECMO support, those who survived to hospital discharge had interstage mortality, progression through consecutive palliation stages, freedom from heart transplantation, and late survival that were comparable to those in patients who did not require ECMO following their Norwood operation.

 

Source: International Journal of Cardiology
Author(s): Pavicevic J, Nguyen TD, Caliskan E, Reser D, Frauenfelder T, Plass A, Stähli BE, Maier W, Seifert B, Maisano F, Falk V, Corti R, Grünenfelder J, Emmert MY.

This is a retrospective review of 260 patients undergoing TAVI, looking at the relationship between aortic valve calcium score and post procedural paravalvular leakage. The results suggest that the amount of calcification significantly impacts the occurrence, the degree and localization of paravalvular leakage after TAVI.

Source: American Journal of Cardiology
Author(s): Buzzatti N, Maisano F, Latib A, Taramasso M, Denti P, La Canna G, Colombo A, Alfieri O.

This is a retrospective study comparing outcomes in 25 octogenarian patients undergoing percutaneous mitral valve intervention with the Mitraclip device and 35 octogenarian patients undergoing surgical mitral valve repair or replacement for isolated mitral regurgitation. Mitraclip patients were older, had higher calculated risk scores, and had worse NYHA functional status. At 30 days, there was  a non significant difference in mortality but there were significantly less complications among Mitraclip patients. Patients in the surgical mitral valve repair or replacement group showed better 2-year survival and freedom from more than grade II mitral regurgitation.

Pages